Penumbra Dividend
Dividend criteria checks 0/6
Penumbra does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 1.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | US$2.35 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors
Apr 12
Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)
Mar 21Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital
Jan 23A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)
Nov 16Penumbra: Appeal Improves, Just Not Appealing Yet
Oct 16Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)
Oct 05Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy
Sep 01A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)
Aug 15Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger
Jun 28Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors
Jun 22Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult
Jun 02We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn
Apr 01Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M
Feb 23Penumbra Riding Higher On Upcoming Launches And Rerating
Jan 12Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy
Nov 03Penumbra cut to Neutral at Citi on macro concerns
Oct 05Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan
Sep 22Penumbra stock rises ~11% after announcing European launch of catheters for stroke care
Sep 07Sector Rerating Has Cast A Shadow Over Penumbra
Aug 18Penumbra gains as RBC initiates at Outperform with 59% upside
Jul 18Penumbra: Multiple Downside Targets, Rescued By Long-Term Value Proposition
Jun 10Penumbra A Little Beaten Down Despite Strong Growth Opportunities
Mar 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PEN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PEN's dividend payments have been increasing.
Dividend Yield vs Market
| Penumbra Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PEN) | n/a |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Medical Equipment) | 1.8% |
| Analyst forecast in 3 Years (PEN) | 0% |
Notable Dividend: Unable to evaluate PEN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PEN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate PEN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PEN has not reported any payouts.